All Stories

  1. Distribution of microRNA Counts Across Human Chromosomes
  2. Medical Benefits and Polymer Applications of Grapes
  3. EWMA Control Chart Integrated with Time Series Models for COVID-19 Surveillance
  4. A Review of Nanotechnology in microRNA Detection and Drug Delivery
  5. Advantages of animal leather over alternatives and its medical applications
  6. Anti-NMDA Receptor Encephalitis, Human Papillomavirus, and microRNA
  7. Beneficial medicinal effects and material applications of rose
  8. The Potential of Collagen Treatment for Comorbid Diseases
  9. Tolerance limits for mixture‐of‐normal distributions with application to COVID‐19 data
  10. Biomaterials in Medical Applications
  11. The Human Pre-miRNA Distance Distribution for Exploring Disease Association
  12. microRNA pathological mechanisms between Parkinson's disease, Alzheimer's disease, glaucoma and macular degeneration
  13. The distance distribution of human microRNAs in MirGeneDB database
  14. Phylogenetic Tree Selection by Testing Substitution Number in Clade
  15. Exploring the Causal Effect of Constipation on Parkinson’s Disease Through Mediation Analysis of Microbial Data
  16. A Pilot Study Exploring the Association of Entacapone, Gut Microbiota, and the Subsequent Side Effects in Patients With Parkinson’s Disease
  17. COVID−19, Anti-NMDA Receptor Encephalitis and MicroRNA
  18. microRNA Biomarkers in Clinical Study
  19. Multiple imputation confidence intervals for the mean of the discrete distributions for incomplete data
  20. A Review of the Effects of Collagen Treatment in Clinical Studies
  21. The Association between Migraine and Depression based on miRNA Biomarkers and Cohort Studies
  22. MicroRNAs, Multiple Sclerosis, and Depression
  23. Editorial: miRNAs and Neurological Diseases
  24. MicroRNAs, Parkinson’s Disease, and Diabetes Mellitus
  25. Confidence intervals for the proportion of conformance
  26. Exploring the Association of Autism Spectrum Disorders and Constipation through Analysis of the Gut Microbiome
  27. Phylogenetic analysis of microRNA biomarkers for amyotrophic lateral sclerosis
  28. The Generalized Bayes Method for High-Dimensional Data Recognition with Applications to Audio Signal Recognition
  29. MicroRNA, Diabetes Mellitus and Colorectal Cancer
  30. The Association between Depression and Gastroesophageal Reflux based on Phylogenetic Analysis of miRNA Biomarkers
  31. <p>Exploring Diversity of COVID‑19 Based on Substitution Distance</p>
  32. Monitoring Change Points by a Sign Change Method
  33. MicroRNAs and Apoptosis in Colorectal Cancer
  34. Constructing exact tolerance intervals for the exponential distribution based on record values
  35. Anti-NMDA Receptor Encephalitis: Efficacy of Treatment for Male Patients and miRNA Biomarker
  36. Logistic Regression Method for Ligand Discovery
  37. Exact two‐sided tolerance interval controlling tail proportions for sample variances
  38. Anti-NMDA Receptor Encephalitis, Vaccination and Virus
  39. Vaccines and Neurological Disease
  40. Phylogenetic Analysis to Explore the Association Between Anti-NMDA Receptor Encephalitis and Tumors Based on microRNA Biomarkers
  41. Tolerance interval for the mixture normal distribution
  42. Exploring MicroRNA Biomarkers for Parkinson’s Disease from mRNA Expression Profiles
  43. How can we identify Amyotrophic Lateral Sclerosis with blood test?
  44. A protocol for investigating the association of vaccination and anti-NMDA receptor encephalitis
  45. Constructing Tolerance Intervals for the Number of Defectives Using Both High- and Low-Resolution Data
  46. Why ALS is often associated with cancers?
  47. A control chart for the lognormal standard deviation
  48. Anti-NMDA Receptor Encephalitis and Vaccination
  49. Predicting MicroRNA Biomarkers for Cancer Using Phylogenetic Tree and Microarray Analysis
  50. On the monitoring of mixture simple linear profiles
  51. Efficacies of treatments for anti-NMDA receptor encephalitis
  52. Corrigendum to “Variance estimation for nucleotide substitution models” [Mol. Phylogenet. Evol. 90 (2015) 97–103]
  53. Multivariate control charts based on the James–Stein estimator
  54. Variance estimation for nucleotide substitution models
  55. Control Charts for the Lognormal Mean
  56. Predicting Cancer-Related MiRNAs Using Expression Profiles in Tumor Tissue
  57. Correction: Investigating microRNA-Target Interaction-Supported Tissues in Human Cancer Tissues Based on miRNA and Target Gene Expression Profiling
  58. Investigating microRNA-Target Interaction-Supported Tissues in Human Cancer Tissues Based on miRNA and Target Gene Expression Profiling
  59. Shrinkage regression-based methods for microarray missing value imputation
  60. RRSM with a data-dependent threshold for miRNA target prediction
  61. Bayesian Ranking Responses in Multiple-Response Questions
  62. Protein-specific Scoring Method for Ligand Discovery
  63. Confidence intervals for a bounded mean in exponential families
  64. Phylogenetic tree selection by the adjustedk-means approach
  65. Human microRNA target identification by RRSM
  66. Yeast cell cycle transcription factors identification by variable selection criteria
  67. Confidence intervals for the substitution number in the nucleotide substitution models
  68. Constructing Biological Pathways by a Two-Step Counting Approach
  69. Approximate Tolerance Limits Under Log-Location-Scale Regression Models in the Presence of Censoring
  70. Closed Form Prediction Intervals Applied for Disease Counts
  71. The monotone boundary property and the full coverage property of confidence intervals for a binomial proportion
  72. Comparison of control charts for low defective rate
  73. Increasing MicroRNA target prediction confidence by the relative R2 method
  74. Tolerance Intervals With Improved Coverage Probabilities for Binomial and Poisson Variables
  75. Improved variance estimators for one- and two-parameter models of nucleotide substitution
  76. Confidence intervals for the mean of a normal distribution with restricted parameter space
  77. Coverage probability of prediction intervals for discrete random variables
  78. Exact average coverage probabilities and confidence coefficients of confidence intervals for discrete distributions
  79. Exact confidence coefficients of simultaneous confidence intervals for multinomial proportions
  80. Ranking responses in multiple-choice questions
  81. ϵ-Admissible Estimators for Normal and Poisson Means
  82. Estimation of the Probability of Passing the USP Dissolution Test
  83. Modified p-values for one-sided testing in restricted parameter spaces
  84. Modified p-Value of Two-Sided Test for Normal Distribution with Restricted Parameter Space
  85. Improved confidence estimators for confidence sets of location parameters
  86. Improved estimation of accuracy in simple hypothesis versus simple alternative testing
  87. Improved confidence estimators for the usual one-sided confidence intervals for the ratio of two normal variances
  88. Admissibility of Confidence Estimators in the Regression Model
  89. The problem of low counts in a signal plus noise model
  90. Brown's paradox in the estimated confidence approach
  91. Estimated confidence under ancillary statistic everywhere-valid constraint
  92. Admissibility of the constant-coverage probability estimator for estimating the coverage function of certain confidence interval